BIONETICS

AcronymDefinition
BIONETICSBio-Inspired Models of Network, Information, and Computing Systems (International Conference)
References in periodicals archive ?
(21) In 1969, the release of a report conducted by the Bionetics Research Laboratories for the National Cancer Institute attracted even more critics.
The others were either recruited through the Ames Bionetics contractor or were laboratory personnel.
The EIA testing was performed simultaneously using Litton Bionetics Amebiasis Bio-Enzabead Screen kit, catalog number 9201-15, which was purchased commercially.
The companies are Abbott Laboratories, Du Pont/Biotech, Electro-Nucleonics, Litton Bionetics, and Travenol-Genentech.
Companies that will support Wyle on this contract include ASRC Federal Space and Defense of Beltsville, Maryland; Logyx, LLC and the SETI Institute both of Mountain View, California; The Bionetics Corp of Yorktown, Virginia; and Paragon TEC of Cleveland.
Murata, "Proposal and evaluation of attractor perturbation-based rate control for stable end-to-end delay," in Proceedings of the 7th International Conference on Bio-Inspired Models of Network, Information, and Computing Systems (BIONETICS '12), pp.
Gallo and their colleagues at the National Cancer Institute in Bethesda, and Bionetics, Inc., in Kensington, Md., report that they had inadvertently used a picture of a virus grown from material provided by Montagnier's laboratory -- thus, LAV-I -- as an illustration in their initial article describing the HTLV-III virus (SN: 4/28/84, p.
Last April, PHS researchers isolated HTLV-III, developed a prototype antibody detection kit, and licensed five firms (Abbott Laboratories, Du Pont/Biotech, Electro-Nucleonics, Litton Bionetics, and Travenol-Genentech) to refine and mass-produce the test kits.
HTLV-III, the virus that causes AIDS, consists of a whole spectrum of closely related but genetically distinct viruses, reports a team of researchers from the National Cancer Institute in Bethesda, Md., Litton Bionetics Inc.
Five firms (Abbott Laboratories, Du Pont/Biotech, Electro-Nucleonics, Litton Bionetics, and Travenol-Genentech) won licenses in June to develop and produce the kits based on a National Cancer Institute prototype.
of Litton Bionetics, Inc., in Rockville, Md., has been working on a vaccine that uses a cancer patient's own tumor cells to prevent recurrence.
Besides Biotech/Du Pont, other licensees are: Abbott Laboratories, North Chicago, Ill.; Electro-Nucleonics, Columbia, Md.; Travenol-Genentech Diagnostics, Cambridge, Mass.; and Litton Bionetics, Kensington, Md.